English | 中文版 | 手機(jī)版 企業(yè)登錄 | 個(gè)人登錄 | 郵件訂閱
當(dāng)前位置 > 首頁(yè) > 技術(shù)文章 > 血液中存在與衰老有關(guān)的代謝分子

血液中存在與衰老有關(guān)的代謝分子

瀏覽次數(shù):6378 發(fā)布日期:2013-7-25  來(lái)源:新聞晚報(bào)
英國(guó)一群科學(xué)家研究發(fā)現(xiàn)一個(gè)革命性的成果:通過(guò)驗(yàn)血,可以判定一個(gè)人能活多長(zhǎng),以及衰老的速度是多快。該科研團(tuán)隊(duì)發(fā)現(xiàn)了人體血液中的一種化學(xué) “指紋”,可以借此判斷一個(gè)人的健康狀況以及衰老速度。
 
相關(guān)研究報(bào)告9日發(fā)表在 《國(guó)際流行病學(xué)雜志》上。據(jù)報(bào)道,研究人員鑒定出血液中含有的22種代謝分子與人體衰老速度、以及老年可能患上的疾病有關(guān)。在這22種代謝分子中,有一種被命名為C-glyTrp的分子,與一個(gè)人的肺功能、骨密度、血壓和膽固醇水平等有密切的關(guān)系。他們認(rèn)為,C-glyTrp代謝分子的等級(jí),將決定一個(gè)人長(zhǎng)大后衰老的速度。
 
此外,該代謝分子還認(rèn)為與嬰兒出生時(shí)的體重有關(guān)。嬰兒出生時(shí)的體重此前就被認(rèn)為是一個(gè)人能否健康衰老的重要因素。這一研究成果或許能夠讓醫(yī)生對(duì)新生兒采取相應(yīng)的措施,避免其在老年時(shí)患上相應(yīng)的病癥。此外,基于這一發(fā)現(xiàn),針對(duì)骨骼問(wèn)題、心臟疾病等與衰老有關(guān)的疾病也可能研發(fā)出新的治療藥物或手段。
 
科研團(tuán)隊(duì)負(fù)責(zé)人、倫敦大學(xué)國(guó)王學(xué)院教授蒂姆·斯佩克特介紹說(shuō):“科學(xué)家很早前就已經(jīng)發(fā)現(xiàn),一個(gè)人出生時(shí)的體重是中年及晚年健康狀況的重要參照,通常來(lái)說(shuō),出生時(shí)體重較輕的人,老年時(shí)更容易患上與衰老有關(guān)的疾病。 ”
 
“此前,出生體重與老年健康狀況之間的關(guān)系,一直沒(méi)有很清晰的分子機(jī)制予以解釋?zhuān)贿^(guò)我們的最新發(fā)現(xiàn)表明,至少有一個(gè)代謝分子能夠證實(shí)兩者之間的關(guān)系。 ”
 
據(jù)報(bào)道,斯佩克特的科研團(tuán)隊(duì)對(duì)超過(guò)6000對(duì)雙胞胎提供的血液樣本進(jìn)行了化驗(yàn)分析,由此發(fā)現(xiàn)22種直接與衰老有關(guān)的代謝分子。同卵雙胞胎擁有相同的基因,但雙胞胎之間的出生體重往往不同,科研人員認(rèn)為,這表明C-glyTrp代謝分子的等級(jí)會(huì)因?yàn)樘涸谧訉m內(nèi)吸收的養(yǎng)分不同等情況發(fā)生改變。
 
科研團(tuán)隊(duì)成員安娜·巴爾德斯介紹說(shuō):“人類(lèi)衰老過(guò)程由基因、生活習(xí)慣、環(huán)境等因素控制。我們的研究首次發(fā)現(xiàn),通過(guò)對(duì)血液的化驗(yàn),能夠確定與衰老速度有關(guān)的代謝分子。通過(guò)進(jìn)一步了解這些代謝分子,我們就能研發(fā)出抗衰老的藥物和療法。而這個(gè)發(fā)現(xiàn)的意義在于,這些代謝分子都是在血液中可檢測(cè)到的,因此我們可以通過(guò)簡(jiǎn)單的驗(yàn)血,了解到自己究竟能夠活多久。 ”
 
Metabolomic markers reveal novel pathways of ageing and early development in human populations
 
Abstract

Background Human ageing is a complex, multifactorial process and early developmental factors affect health outcomes in old age.

Methods Metabolomic profiling on fasting blood was carried out in 6055 individuals from the UK. Stepwise regression was performed to identify a panel of independent metabolites which could be used as a surrogate for age. We also investigated the association with birthweight overall and within identical discordant twins and with genome-wide methylation levels.

Results We identified a panel of 22 metabolites which combined are strongly correlated with age (R2 = 59%) and with age-related clinical traits independently of age. One particular metabolite, C-glycosyl tryptophan (C-glyTrp), correlated strongly with age (beta = 0.03, SE = 0.001, P = 7.0 × 10−157) and lung function (FEV1 beta = −0.04, SE = 0.008, P = 1.8 × 10−8 adjusted for age and confounders) and was replicated in an independent population (n = 887). C-glyTrp was also associated with bone mineral density (beta = −0.01, SE = 0.002, P = 1.9 × 10−6) and birthweight (beta = −0.06, SE = 0.01, P = 2.5 × 10−9). The difference in C-glyTrp levels explained 9.4% of the variance in the difference in birthweight between monozygotic twins. An epigenome-wide association study in 172 individuals identified three CpG-sites, associated with levels of C-glyTrp (P < 2 × 10−6). We replicated one CpG site in the promoter of the WDR85 gene in an independent sample of 350 individuals (beta = −0.20, SE = 0.04, P = 2.9 × 10−8). WDR85 is a regulator of translation elongation factor 2, essential for protein synthesis in eukaryotes.

Conclusions Our data illustrate how metabolomic profiling linked with epigenetic studies can identify some key molecular mechanisms potentially determined in early development that produce long-term physiological changes influencing human health and ageing.


標(biāo)簽: 血液 衰老 代謝分子
用戶(hù)名: 密碼: 匿名 快速注冊(cè) 忘記密碼
評(píng)論只代表網(wǎng)友觀點(diǎn),不代表本站觀點(diǎn)。 請(qǐng)輸入驗(yàn)證碼: 8795
Copyright(C) 1998-2024 生物器材網(wǎng) 電話(huà):021-64166852;13621656896 E-mail:info@bio-equip.com